Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upM. Dreyling, Marco Ladetto, Elı́as Campo et al.|Annals of Oncology|2017Cited by 736
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upM. Dreyling, Mats Jerkeman, Michele Ghielmini et al.|Annals of Oncology|2020Cited by 267
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upM. Dreyling, Marco Ladetto, Michele Ghielmini et al.|Annals of Oncology|2016Cited by 228
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upM. Dreyling, Marco Ladetto, Carsten Geisler et al.|Annals of Oncology|2014Cited by 136
Efficacy of R‐BAC in relapsed, refractory mantle cell lymphoma post BTK inhibitor therapyRory McCulloch, Simon Rule, Carlo Visco et al.|British Journal of Haematology|2020Cited by 72